Home/Filings/4/0001193125-26-018316
4//SEC Filing

Gerard Michael 4

Accession 0001193125-26-018316

CIK 0001759138other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 6:53 PM ET

Size

5.0 KB

Accession

0001193125-26-018316

Research Summary

AI-generated summary of this filing

Updated

Cabaletta Bio (CABA) General Counsel Gerard Michael Buys 6,600 Shares

What Happened
Gerard Michael, General Counsel of Cabaletta Bio, purchased 6,600 shares of CABA stock in an open-market/ private purchase transaction on January 21, 2026. The reported weighted-average price was $2.27 per share for a total reported value of $14,979. This was a purchase (insider buy), which some investors view as a modest positive signal about the insider's view.

Key Details

  • Transaction date: 2026-01-21 (reported on Form 4 filed 2026-01-21) — filing appears timely.
  • Transaction type/code: Purchase (P) — open market or private purchase.
  • Shares purchased: 6,600 shares.
  • Price: weighted-average $2.27 per share; footnote F1 states purchases ranged from $2.269 to $2.2699 and full breakdown can be provided on request.
  • Total reported value: $14,979.
  • Shares owned after transaction: Not specified in the information provided in this summary.
  • No 10b5-1 plan, tax withholding, option exercise, or gift noted in the provided filing details.

Context
This was a straightforward open-market purchase rather than an option exercise or award. The dollar amount is relatively small (~$15K), so while purchases can be informative, the size here is modest. No evidence in the filing suggests late reporting or other special conditions.

Insider Transaction Report

Form 4
Period: 2026-01-21
Gerard Michael
General Counsel
Transactions
  • Purchase

    Common Stock

    [F1]
    2026-01-21$2.27/sh+6,600$14,9796,600 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $2.269 to $2.2699, inclusive. The reporting person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Signature
By: /s/ Michael Gerard|2026-01-21

Documents

1 file

Issuer

Cabaletta Bio, Inc.

CIK 0001759138

Entity typeother

Related Parties

1
  • filerCIK 0001881529

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 6:53 PM ET
Size
5.0 KB